Related references
Note: Only part of the references are listed.Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers
Mark B. Sostek et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials
Marc C. Hochberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone
J. L. Goldstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients
L. Laine et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Guidelines for Prevention of NSAID-Related Ulcer Complications
Frank L. Lanza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis
Nicholas Latimer et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users
Neena S. Abraham et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents
Francis K. L. Chan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
A 51-year-old woman with shortness of breath and edema
Sonali Desai et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Deepak L. Bhatt et al.
CIRCULATION (2008)
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
W. Zhang et al.
OSTEOARTHRITIS AND CARTILAGE (2008)
Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage
E. M. Van Soest et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Use of nonsteroidal Antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association
Elliott M. Antman et al.
CIRCULATION (2007)
Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs
C. J. Hawkey et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications
Jay L. Goldstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications
KC Lai et al.
AMERICAN JOURNAL OF MEDICINE (2005)
National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs
NS Abraham et al.
GASTROENTEROLOGY (2005)
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
W Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis
L Rabeneck et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors
C Hawkey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Adherence to proton pump inhibitors or H-2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs
MCJM Sturkenboom et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Measuring dyspepsia-related health in randomized trials: the Severity of Dyspepsia Assessment (SODA) and its use in treatment with NSAIDs and COX-2-specific inhibitors
L Rabeneck
RHEUMATOLOGY (2003)
SODA (severity of dyspepsia assessment): A new effective outcome measure for dyspepsia-related health
L Rabeneck et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Share Paper
